6.12
price up icon0.49%   0.03
 
loading
前日終値:
$6.09
開ける:
$6.09
24時間の取引高:
1.09M
Relative Volume:
0.83
時価総額:
$167.79M
収益:
$160.43M
当期純損益:
$-227.64M
株価収益率:
-0.089
EPS:
-68.77
ネットキャッシュフロー:
$-170.79M
1週間 パフォーマンス:
-1.61%
1か月 パフォーマンス:
+28.03%
6か月 パフォーマンス:
+67.21%
1年 パフォーマンス:
-10.66%
1日の値動き範囲:
Value
$5.67
$6.14
1週間の範囲:
Value
$5.67
$6.96
52週間の値動き範囲:
Value
$1.38
$7.34

Agenus Inc Stock (AGEN) Company Profile

Name
名前
Agenus Inc
Name
セクター
Healthcare (1161)
Name
電話
781-674-4410
Name
住所
3 FORBES ROAD, LEXINGTON, MA
Name
職員
316
Name
Twitter
@Agenus_Bio
Name
次回の収益日
2024-12-05
Name
最新のSEC提出書
Name
AGEN's Discussions on Twitter

AGEN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AGEN
Agenus Inc
6.12 170.53M 160.43M -227.64M -170.79M -68.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Agenus Inc Stock (AGEN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-04 アップグレード H.C. Wainwright Neutral → Buy
2024-07-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-18 ダウングレード H.C. Wainwright Buy → Neutral
2024-07-18 ダウングレード William Blair Outperform → Mkt Perform
2023-06-06 開始されました Robert W. Baird Outperform
2023-02-28 再開されました H.C. Wainwright Buy
2022-09-28 開始されました SMBC Nikko Outperform
2021-12-16 開始されました H.C. Wainwright Buy
2019-11-19 再開されました B. Riley FBR Buy
2019-04-22 開始されました B. Riley FBR Buy
2016-10-28 ダウングレード H.C. Wainwright Buy → Neutral
2016-10-27 繰り返されました Maxim Group Buy
2016-03-11 アップグレード Maxim Group Hold → Buy
2015-12-16 開始されました Jefferies Buy
2015-10-27 ダウングレード Maxim Group Buy → Hold
2015-07-27 繰り返されました MLV & Co Buy
2015-06-11 開始されました Oppenheimer Outperform
2015-01-12 繰り返されました Maxim Group Buy
2015-01-09 繰り返されました MLV & Co Buy
2015-01-09 繰り返されました Maxim Group Buy
2014-12-19 繰り返されました Maxim Group Buy
2014-05-08 繰り返されました Maxim Group Buy
2014-03-14 繰り返されました MLV & Co Buy
2013-10-08 繰り返されました Maxim Group Buy
2012-01-05 開始されました William Blair Outperform
2011-12-01 開始されました Global Hunter Securities Buy
すべてを表示

Agenus Inc (AGEN) 最新ニュース

pulisher
04:41 AM

What analysts say about Agenus Inc. stockFree Capital Efficiency Planning - Autocar Professional

04:41 AM
pulisher
03:17 AM

Agenus Inc. Stock Analysis and ForecastExplosive trading opportunities - jammulinksnews.com

03:17 AM
pulisher
Jul 22, 2025

What drives Agenus Inc. stock priceAccelerated investment success - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits - Finansavisen

Jul 22, 2025
pulisher
Jul 21, 2025

Is Agenus Inc. a good long term investmentFree High-Return Strategy Alerts - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

Colon cancer impacts far more than just the body – Agenus - Oncodaily

Jul 19, 2025
pulisher
Jul 15, 2025

Agenus unit, MiNK surges after peer-reviewed data for lead drug - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Zydus Lifesciences receives final approval from USFDA for Celecoxib Capsules - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

AGEN Stock Outpaces Medical Sector Peers This Year - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

Agenus (AGEN) Surges 19.3%: Is This an Indication of Further Gains? - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

Public Companies Hold Majority of MiNK Therapeutics Stock After 815% Gain - AInvest

Jul 14, 2025
pulisher
Jul 12, 2025

Agenus Responds to New Regulatory Environment at FDA - Oncodaily

Jul 12, 2025
pulisher
Jul 11, 2025

Agenus Inc. shares surge 19.54% intraday after positive clinical data and strategic partnership. - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Zacks.com featured highlights Yext, Agenus and NCR Voyix - The Globe and Mail

Jul 10, 2025
pulisher
Jul 08, 2025

Agenus stock maintains Buy rating at H.C. Wainwright after positive bot/bal data - Investing.com Canada

Jul 08, 2025
pulisher
Jul 08, 2025

Investors Turn to Cancer Breakthroughs as Federal Funding Faces Deep Cuts - Baystreet.ca

Jul 08, 2025
pulisher
Jul 08, 2025

Agenus stock maintains Buy rating at H.C. Wainwright after positive bot/bal data By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 07, 2025

Agenus Inc. shares fall 1.35% in after-hours trading after FDA questions efficacy data for BOT/BAL combination. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Botensilimab and Balstilimab Achieves 21-Month Survival in mCRC and FDA Endorsement for Global Phase 3 Trial - Oncodaily

Jul 07, 2025
pulisher
Jul 07, 2025

Agenus' BOT/BAL in MSS CRC: A Breakthrough with Accelerated Approval on the Horizon? - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Agenus reports 42% two-year survival in colorectal cancer trial - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Agenus' BOT/BAL Combo Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward FDA Registration with Phase 3 Trial Design Alignment. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

42% Survival Rate: Agenus Cancer Drug Shows Breakthrough in Resistant Colorectal Cancer | AGEN Stock News - Stock Titan

Jul 07, 2025
pulisher
Jul 07, 2025

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Jul 07, 2025
pulisher
Jul 03, 2025

Agenus Inc. shares surge 8.17% intraday after HC Wainwright & Co. analyst upgrades rating to strong buy. - AInvest

Jul 03, 2025
pulisher
Jul 03, 2025

Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN

Jul 03, 2025
pulisher
Jun 30, 2025

Agenus Requests to Dismiss Class Action Filed by Investors - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

Agenus Inc.(NasdaqCM: AGEN) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Agenus Inc.(NasdaqCM: AGEN) dropped from Russell 2000 Growth Index - MarketScreener

Jun 29, 2025
pulisher
Jun 29, 2025

Agenus Inc.(NasdaqCM: AGEN) dropped from Russell 2500 Index - MarketScreener

Jun 29, 2025
pulisher
Jun 20, 2025

2 East Bay drugmaking sites sold to Indian manufacturer - The Business Journals

Jun 20, 2025
pulisher
Jun 18, 2025

# Agenus and Noetik partner to develop AI-powered cancer treatment biomarkers - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock - MSN

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus (AGEN) and Noetik Collaborate to Enhance Cancer Treatment - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus, Noetik Enter Research Collaboration - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology | AGEN Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

AI Breakthrough: Agenus and Noetik Join Forces to Revolutionize Cancer Patient Selection Using Virtual Cell Models - Stock Titan

Jun 17, 2025
pulisher
Jun 15, 2025

10 Most Undervalued Stocks to Buy for Under $5 - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Is Zydus’s Agenus Deal Opportunistic Or Strategic? - insights.citeline.com

Jun 12, 2025
pulisher
Jun 11, 2025

Agenus Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 10, 2025

H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus Announces Virtual Annual Shareholders Meeting - New Castle News

Jun 10, 2025
pulisher
Jun 10, 2025

How to Join Agenus 2025 Virtual Shareholders Meeting: Complete Registration Guide - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus' 2025 Annual Meeting Highlights Pipeline Breakthroughs and Governance Gains, Bolstering Oncology Innovation Play - AInvest

Jun 10, 2025
pulisher
Jun 09, 2025

Agenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jun 09, 2025

Agenus Inc (AGEN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
大文字化:     |  ボリューム (24 時間):